000			01738ngm a2200373 a 4500
001			HST3599_1_2
003			UkLoHST
006			m c
007			cr|cna|||a||||
007			vz|czazum
008			130716s2013 enk|||||||||||s|||v|eng d
028	5	0	_a3599 _bHenry Stewart Talks
035			_a(UkLoHST)2570
040			_aUkLoHST _beng _cUkLoHST
100	1		_aRobert, Caroline, _u(Institute Gustave Roussy, France) _4spk
245	1	0	_aSkin side effects targeted anti-EGFR and anti-BRAF therapies _h[electronic resource] / _cCaroline Robert.
260			_aLondon : _bHenry Stewart Talks, _c2013.
300			_a1 online resource (1 streaming video file (50 min.) : _bcolor, sound).
490	1		_aThe biomedical & life sciences collection, _x2056-452X
500			_aAnimated audio-visual presentation with synchronized narration.
500			_aTitle from title frames.
505	0		_aContents: Clinical presentation of skin adverse events occurring during anti-EGFR, anti-MEK and anti-BRAF agents -- Mechanisms underlying skin manifestation of targeted anticancer agents -- Management of the patients presenting with skin adverse events due to targeted anticancer agents.
506			_aAccess restricted to subscribers.
538			_aMode of access: World Wide Web.
650		0	_aAntineoplastic agents _xSide effects.
650		0	_aCancer _xChemotherapy _xComplications.
650		0	_aChemotherapy _xComplications.
650		2	_aAntineoplastic Agents _xadverse effects.
650		2	_aAntineoplastic Agents _xtherapeutic use.
650		2	_aNeoplasms _xcomplications.
650		2	_aNeoplasms _xdrug therapy.
830		0	_aHenry Stewart talks. _pBiomedical & life sciences collection.
856	4	0	_uhttps://hstalks.com/bs/2570/
999			_c77203 _d77203